Juvenile papillomatosis is not a well known clinicopathologic entity. It is an underdiagnosed entity [2]. Radiologists, pathologists, and clinicians must work together to overcome diagnostic difficulties. 

Although juvenile papillomatosis is benign pathology, patients with juvenile papillomatosis have increased risk for breast cancer [1]. Because of this relationship, distinguishing this clinicopathological entity from other benign breast lesions is essential.

Patients who diagnosed with juvenile papillomatosis have to have more strict and early follow-ups than the healthy population [1,2,3,4].

The name of the juvenile is a pitfall. Radiologists, pathologists, and clinicians must be aware of this and keep in mind this diagnosis even in the postmenopausal period.